2021
DOI: 10.1186/s12879-021-06537-2
|View full text |Cite
|
Sign up to set email alerts
|

Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain

Abstract: Background Indicator condition guided HIV testing is a proven effective strategy for increasing HIV diagnosis in health care facilities. As part of the INTEGRATE Joint Action, we conducted four pilot studies, aiming to increase integrated testing for HIV/HCV/HBV and sexually transmitted infections, by introducing and expanding existing indicator condition guided HIV testing methods. Methods Pilot interventions included combined HIV/HCV testing in a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 6 publications
(16 reference statements)
0
2
0
Order By: Relevance
“…Integrated testing across multiple disease domains (tuberculosis, HIV, STIs, etc.) has proven successful to increase outreach, optimize resources and improve case‐finding 19 . Routine healthcare evaluations could also include hepatitis screening.…”
Section: Discussionmentioning
confidence: 99%
“…Integrated testing across multiple disease domains (tuberculosis, HIV, STIs, etc.) has proven successful to increase outreach, optimize resources and improve case‐finding 19 . Routine healthcare evaluations could also include hepatitis screening.…”
Section: Discussionmentioning
confidence: 99%
“…The high cost of testing and of case finding is therefore a potential barrier to more widespread and non-targeted testing in workplaces. The cost of workplace testing would be further increased if additional tests were included such as hepatitis B and hepatitis C (e.g., Matulionytė and colleagues [ 75 ]). Conversely, including these tests might increase the number of cases of blood borne viruses identified overall; and the cost of case finding for hepatitis B and hepatitis C is often lower than that for HIV [ 76 , 77 ] therefore improving the overall cost/ benefit balance.…”
Section: Discussionmentioning
confidence: 99%